StonvexLoading…
StonvexStonvexStonvexCore line items from CHRW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.23B | $17.72B | $17.60B | $24.70B |
Operating Income | $794.96M | $669.14M | $514.61M | $1.27B |
Net Income | $587.08M | $465.69M | $325.13M | $940.52M |
EPS (Diluted) | $4.83 | $3.86 | $2.72 | $7.40 |
Total Assets | $5.06B | $5.30B | $5.23B | $5.95B |
Total Liabilities | $3.21B | $3.58B | $3.81B | $4.60B |
Cash & Equivalents | $160.87M | $145.76M | $145.52M | $217.48M |
Free Cash Flow OCF − CapEx | $894.89M | $486.43M | $701.96M | $1.59B |
Shares Outstanding | 118.43M | 118.66M | 116.77M | 116.32M |